John K C Li

Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection

O. Tsang, E. Lau, M. Peiris, 2021, EClinicalMedicine.

Natural Reassortment of Eurasian Avian-Like Swine H1N1 and Avian H9N2 Influenza Viruses in Pigs, China

Ricky K. N. Wong, M. Peiris, Wanying Sun, 2022, Emerging infectious diseases.

SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022

M. Peiris, L. Poon, S. Cheng, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

M. Peiris, S. Valkenburg, P. Ip, 2022, Nature Communications.

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

L. Poon, E. Lau, M. Peiris, 2022, Nature Medicine.

Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection

R. Webby, M. Peiris, L. Poon, 2022, Journal of Clinical Virology.

Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccine

B. Cowling, G. Leung, J. Peiris, 2022, medRxiv.